Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC6A18 SLC6A4 MCOLN1 CNGA1 SLC6A14	2.54e-05	171	41	5	GO:0015081
GeneOntologyMolecularFunction	MHC protein complex binding	LILRB5 HLA-DRB4 HLA-DRB5	8.11e-05	41	41	3	GO:0023023
GeneOntologyMolecularFunction	G protein-coupled acetylcholine receptor activity	CHRM1 CHRM4	8.58e-05	7	41	2	GO:0016907
GeneOntologyMolecularFunction	protein-glutamine gamma-glutamyltransferase activity	TGM1 TGM3	1.47e-04	9	41	2	GO:0003810
GeneOntologyMolecularFunction	CD4 receptor binding	CD22 HLA-DRB5	2.24e-04	11	41	2	GO:0042609
GeneOntologyMolecularFunction	IgM binding	CD22 LILRB5	2.24e-04	11	41	2	GO:0001791
GeneOntologyMolecularFunction	prostanoid receptor activity	TBXA2R PTGER2	2.68e-04	12	41	2	GO:0004954
GeneOntologyMolecularFunction	G protein-coupled neurotransmitter receptor activity	CHRM1 CHRM4	3.16e-04	13	41	2	GO:0099528
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC6A18 SLC6A4 CACNG6 MCOLN1 CNGA1 SLC6A14	3.48e-04	465	41	6	GO:0046873
GeneOntologyMolecularFunction	carbohydrate binding	SIGLEC14 CRYBG1 CHIA CD22 HLA-DRB5	4.14e-04	310	41	5	GO:0030246
GeneOntologyMolecularFunction	icosanoid receptor activity	TBXA2R PTGER2	4.85e-04	16	41	2	GO:0004953
GeneOntologyMolecularFunction	sodium:chloride symporter activity	SLC6A18 SLC6A4	5.49e-04	17	41	2	GO:0015378
GeneOntologyMolecularFunction	serine-type endopeptidase activity	C2 PRSS2 CELA2B CELA2A	6.11e-04	190	41	4	GO:0004252
GeneOntologyMolecularFunction	solute:sodium symporter activity	SLC6A18 SLC6A4 SLC6A14	6.13e-04	81	41	3	GO:0015370
GeneOntologyMolecularFunction	monoatomic anion:sodium symporter activity	SLC6A18 SLC6A4	6.88e-04	19	41	2	GO:0015373
GeneOntologyMolecularFunction	serine-type peptidase activity	C2 PRSS2 CELA2B CELA2A	8.41e-04	207	41	4	GO:0008236
GeneOntologyMolecularFunction	serine hydrolase activity	C2 PRSS2 CELA2B CELA2A	9.19e-04	212	41	4	GO:0017171
GeneOntologyMolecularFunction	G protein-coupled serotonin receptor activity	CHRM1 CHRM4	9.26e-04	22	41	2	GO:0004993
GeneOntologyMolecularFunction	acetylcholine receptor activity	CHRM1 CHRM4	1.01e-03	23	41	2	GO:0015464
GeneOntologyMolecularFunction	chloride:monoatomic cation symporter activity	SLC6A18 SLC6A4	1.01e-03	23	41	2	GO:0015377
GeneOntologyMolecularFunction	amino acid:sodium symporter activity	SLC6A18 SLC6A14	1.01e-03	23	41	2	GO:0005283
GeneOntologyMolecularFunction	sialic acid binding	SIGLEC14 CD22	1.20e-03	25	41	2	GO:0033691
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	TBXA2R PLCD4 MYCBP2 CHRM4	1.26e-03	231	41	4	GO:0005085
GeneOntologyMolecularFunction	phosphatidylinositol phospholipase C activity	PLCD4 CHRM1	1.30e-03	26	41	2	GO:0004435
GeneOntologyMolecularFunction	monoatomic anion:monoatomic cation symporter activity	SLC6A18 SLC6A4	1.30e-03	26	41	2	GO:0015296
GeneOntologyMolecularFunction	MHC class II protein complex binding	HLA-DRB4 HLA-DRB5	1.40e-03	27	41	2	GO:0023026
GeneOntologyMolecularFunction	amino acid:monoatomic cation symporter activity	SLC6A18 SLC6A14	1.61e-03	29	41	2	GO:0005416
GeneOntologyMolecularFunction	phospholipase C activity	PLCD4 CHRM1	1.61e-03	29	41	2	GO:0004629
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	SLC6A18 SLC6A4 CACNG6 MCOLN1 CNGA1 SLC6A14	1.65e-03	627	41	6	GO:0022890
GeneOntologyMolecularFunction	endopeptidase activity	C2 PRSS2 MME CELA2B CELA2A	1.79e-03	430	41	5	GO:0004175
GeneOntologyMolecularFunction	solute:monoatomic cation symporter activity	SLC6A18 SLC6A4 SLC6A14	1.87e-03	119	41	3	GO:0015294
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	MCOLN1 CNGA1	2.09e-03	33	41	2	GO:0005217
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	SLC6A18 SLC6A4 CACNG6 MCOLN1 CNGA1 SLC6A14	2.20e-03	664	41	6	GO:0008324
GeneOntologyMolecularFunction	calcium channel activity	CACNG6 MCOLN1 CNGA1	2.35e-03	129	41	3	GO:0005262
GeneOntologyMolecularFunction	transmembrane transporter activity	SLC6A18 SLC6A4 CACNG6 MCOLN1 ABCA13 CNGA1 ABCA7 SLC6A14	2.42e-03	1180	41	8	GO:0022857
GeneOntologyMolecularFunction	immunoglobulin binding	CD22 LILRB5	2.48e-03	36	41	2	GO:0019865
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC6A18 SLC6A4 ABCA13 ABCA7 SLC6A14	2.81e-03	477	41	5	GO:0022804
GeneOntologyMolecularFunction	G protein-coupled amine receptor activity	CHRM1 CHRM4	3.21e-03	41	41	2	GO:0008227
GeneOntologyMolecularFunction	neutral L-amino acid transmembrane transporter activity	SLC6A18 SLC6A14	3.21e-03	41	41	2	GO:0015175
GeneOntologyMolecularFunction	symporter activity	SLC6A18 SLC6A4 SLC6A14	3.59e-03	150	41	3	GO:0015293
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	SLC6A18 SLC6A4 MCOLN1	3.66e-03	151	41	3	GO:0008509
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNG6 MCOLN1 CNGA1	3.66e-03	151	41	3	GO:0015085
GeneOntologyMolecularFunction	peptide binding	MME LILRB5 HLA-DRB4 HLA-DRB5	4.02e-03	318	41	4	GO:0042277
GeneOntologyMolecularFunction	transporter activity	SLC6A18 SLC6A4 CACNG6 MCOLN1 ABCA13 CNGA1 ABCA7 SLC6A14	4.17e-03	1289	41	8	GO:0005215
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	SLC6A18 SLC6A4 CACNG6 MCOLN1 CNGA1 SLC6A14	4.24e-03	758	41	6	GO:0015318
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA13 ABCA7	4.55e-03	49	41	2	GO:0140359
GeneOntologyMolecularFunction	peptide antigen binding	HLA-DRB4 HLA-DRB5	4.55e-03	49	41	2	GO:0042605
GeneOntologyMolecularFunction	sodium channel activity	MCOLN1 CNGA1	5.11e-03	52	41	2	GO:0005272
GeneOntologyMolecularFunction	monoatomic cation channel activity	SLC6A4 CACNG6 MCOLN1 CNGA1	5.25e-03	343	41	4	GO:0005261
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	SLC6A18 SLC6A4 CACNG6 MCOLN1 CNGA1 SLC6A14	5.28e-03	793	41	6	GO:0015075
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	TBXA2R TNFRSF25 PTGER2 CHRM1 ABCA7 CHRM4 LILRB5 HLA-DRB5	5.58e-03	1353	41	8	GO:0004888
GeneOntologyMolecularFunction	coreceptor activity	CD22 LILRB5	9.60e-03	72	41	2	GO:0015026
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	CHRM1 CHRM4	1.04e-02	75	41	2	GO:0098960
GeneOntologyMolecularFunction	peptidase activity	C2 PRSS2 MME CELA2B CELA2A	1.05e-02	654	41	5	GO:0008233
GeneOntologyMolecularFunction	carboxylic acid binding	SIGLEC14 DMBT1 CD22	1.29e-02	239	41	3	GO:0031406
GeneOntologyMolecularFunction	cargo receptor activity	DMBT1 ABCA7	1.32e-02	85	41	2	GO:0038024
GeneOntologyMolecularFunction	monoatomic ion channel activity	SLC6A4 CACNG6 MCOLN1 CNGA1	1.43e-02	459	41	4	GO:0005216
GeneOntologyMolecularFunction	organic acid binding	SIGLEC14 DMBT1 CD22	1.52e-02	254	41	3	GO:0043177
GeneOntologyMolecularFunction	phosphoric diester hydrolase activity	PLCD4 CHRM1	1.69e-02	97	41	2	GO:0008081
GeneOntologyBiologicalProcess	peptide cross-linking	TGM1 TGM3 ABCA7	2.06e-05	27	41	3	GO:0018149
GeneOntologyBiologicalProcess	sodium ion transmembrane transport	SLC6A18 SLC6A4 MCOLN1 CNGA1 SLC6A14	5.54e-05	208	41	5	GO:0035725
GeneOntologyBiologicalProcess	conditioned place preference	SLC6A4 CSMD1	5.75e-05	6	41	2	GO:1990708
GeneOntologyBiologicalProcess	positive regulation of apoptotic cell clearance	C2 ABCA7	1.07e-04	8	41	2	GO:2000427
GeneOntologyBiologicalProcess	amyloid-beta clearance by cellular catabolic process	MME ABCA7	1.07e-04	8	41	2	GO:0150094
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway	CHRM1 CHRM4	1.07e-04	8	41	2	GO:0007197
GeneOntologyBiologicalProcess	regulation of apoptotic cell clearance	C2 ABCA7	1.72e-04	10	41	2	GO:2000425
GeneOntologyBiologicalProcess	cognition	SLC6A4 MME CSMD1 CHRM1 ABCA7 LILRB5	1.76e-04	423	41	6	GO:0050890
GeneOntologyBiologicalProcess	sodium ion transport	SLC6A18 SLC6A4 MCOLN1 CNGA1 SLC6A14	2.06e-04	275	41	5	GO:0006814
GeneOntologyBiologicalProcess	MHC class II protein complex assembly	HLA-DRB4 HLA-DRB5	4.55e-04	16	41	2	GO:0002399
GeneOntologyBiologicalProcess	peptide antigen assembly with MHC class II protein complex	HLA-DRB4 HLA-DRB5	4.55e-04	16	41	2	GO:0002503
GeneOntologyCellularComponent	keratohyalin granule	CELA2B CELA2A	3.93e-05	5	42	2	GO:0036457
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	SLC6A4 SIGLEC14 MME DMBT1 DCSTAMP MCOLN1 ABCA13 ABCA7 HLA-DRB4 HLA-DRB5	2.06e-04	1307	42	10	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	SLC6A4 SIGLEC14 MME DMBT1 DCSTAMP MCOLN1 ABCA13 ABCA7 HLA-DRB4 HLA-DRB5	2.30e-04	1325	42	10	GO:0012506
GeneOntologyCellularComponent	MHC class II protein complex	HLA-DRB4 HLA-DRB5	5.26e-04	17	42	2	GO:0042613
GeneOntologyCellularComponent	endocytic vesicle membrane	DMBT1 MCOLN1 HLA-DRB4 HLA-DRB5	8.51e-04	212	42	4	GO:0030666
GeneOntologyCellularComponent	neuron projection terminus	MME CHRM1 CNGA1 CHRM4	1.21e-03	233	42	4	GO:0044306
GeneOntologyCellularComponent	endosome membrane	SLC6A4 DCSTAMP MCOLN1 ABCA7 HLA-DRB4 HLA-DRB5	1.21e-03	602	42	6	GO:0010008
GeneOntologyCellularComponent	MHC protein complex	HLA-DRB4 HLA-DRB5	1.24e-03	26	42	2	GO:0042611
GeneOntologyCellularComponent	phagocytic cup	MCOLN1 ABCA7	1.77e-03	31	42	2	GO:0001891
GeneOntologyCellularComponent	endosome	SLC6A4 MME DCSTAMP CD22 MCOLN1 ABCA7 HLA-DRB4 HLA-DRB5	1.99e-03	1167	42	8	GO:0005768
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-DRB4 HLA-DRB5	2.25e-03	35	42	2	GO:0098553
GeneOntologyCellularComponent	brush border	SLC6A18 MME SLC6A14	3.52e-03	152	42	3	GO:0005903
GeneOntologyCellularComponent	collagen-containing extracellular matrix	TGM3 PRSS2 CELA2B DMBT1 CELA2A	4.03e-03	530	42	5	GO:0062023
GeneOntologyCellularComponent	lumenal side of membrane	HLA-DRB4 HLA-DRB5	4.19e-03	48	42	2	GO:0098576
GeneOntologyCellularComponent	secretory granule membrane	SIGLEC14 MME DMBT1 ABCA13	4.21e-03	329	42	4	GO:0030667
GeneOntologyCellularComponent	lysosome	SIGLEC14 PRSS2 MCOLN1 ABCA13 HLA-DRB4 HLA-DRB5	5.33e-03	811	42	6	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	SIGLEC14 PRSS2 MCOLN1 ABCA13 HLA-DRB4 HLA-DRB5	5.33e-03	811	42	6	GO:0000323
GeneOntologyCellularComponent	late endosome membrane	MCOLN1 HLA-DRB4 HLA-DRB5	5.55e-03	179	42	3	GO:0031902
Domain	NA_NEUROTRAN_SYMP_2	SLC6A18 SLC6A4 SLC6A14	7.26e-06	18	40	3	PS00754
Domain	NA_NEUROTRAN_SYMP_3	SLC6A18 SLC6A4 SLC6A14	8.61e-06	19	40	3	PS50267
Domain	SNF	SLC6A18 SLC6A4 SLC6A14	8.61e-06	19	40	3	PF00209
Domain	Na/ntran_symport	SLC6A18 SLC6A4 SLC6A14	8.61e-06	19	40	3	IPR000175
Domain	NA_NEUROTRAN_SYMP_1	SLC6A18 SLC6A4 SLC6A14	8.61e-06	19	40	3	PS00610
Domain	TRYPSIN_SER	C2 PRSS2 CELA2B CELA2A	4.04e-05	90	40	4	IPR033116
Domain	Thbox_rcpt	TBXA2R PTGER2	4.45e-05	5	40	2	IPR001105
Domain	Musac_Ach_rcpt	CHRM1 CHRM4	4.45e-05	5	40	2	IPR000995
Domain	-	SIGLEC14 TGM1 TGM3 CD22 MYCBP2 LILRB5 HLA-DRB4 HLA-DRB5	6.79e-05	663	40	8	2.60.40.10
Domain	TRYPSIN_HIS	C2 PRSS2 CELA2B CELA2A	6.84e-05	103	40	4	IPR018114
Domain	TRYPSIN_SER	C2 PRSS2 CELA2B CELA2A	7.65e-05	106	40	4	PS00135
Domain	TRYPSIN_HIS	C2 PRSS2 CELA2B CELA2A	7.94e-05	107	40	4	PS00134
Domain	Peptidase_S1A	C2 PRSS2 CELA2B CELA2A	9.81e-05	113	40	4	IPR001314
Domain	TRYPSIN_DOM	C2 PRSS2 CELA2B CELA2A	1.05e-04	115	40	4	PS50240
Domain	Ig-like_fold	SIGLEC14 TGM1 TGM3 CD22 MYCBP2 LILRB5 HLA-DRB4 HLA-DRB5	1.05e-04	706	40	8	IPR013783
Domain	Tryp_SPc	C2 PRSS2 CELA2B CELA2A	1.12e-04	117	40	4	SM00020
Domain	Prostanoid_rcpt	TBXA2R PTGER2	1.24e-04	8	40	2	IPR008365
Domain	MHC_II_b_N	HLA-DRB4 HLA-DRB5	1.24e-04	8	40	2	PD000328
Domain	Trypsin	C2 PRSS2 CELA2B CELA2A	1.28e-04	121	40	4	PF00089
Domain	Trypsin_dom	C2 PRSS2 CELA2B CELA2A	1.28e-04	121	40	4	IPR001254
Domain	Peptidase_S1_PA	C2 PRSS2 CELA2B CELA2A	1.36e-04	123	40	4	IPR009003
Domain	Transglut_N	TGM1 TGM3	1.59e-04	9	40	2	PF00868
Domain	TRANSGLUTAMINASES	TGM1 TGM3	1.59e-04	9	40	2	PS00547
Domain	Transglutaminase_N	TGM1 TGM3	1.59e-04	9	40	2	IPR001102
Domain	MHC_II_beta	HLA-DRB4 HLA-DRB5	1.59e-04	9	40	2	PF00969
Domain	MHC_II_b_N	HLA-DRB4 HLA-DRB5	1.59e-04	9	40	2	IPR000353
Domain	Transglut_C	TGM1 TGM3	1.59e-04	9	40	2	PF00927
Domain	-	TGM1 TGM3	1.59e-04	9	40	2	3.90.260.10
Domain	Gln_gamma-glutamylTfrase_euk	TGM1 TGM3	1.59e-04	9	40	2	IPR023608
Domain	Transglutaminase_AS	TGM1 TGM3	1.59e-04	9	40	2	IPR013808
Domain	MHC_II_beta	HLA-DRB4 HLA-DRB5	1.59e-04	9	40	2	SM00921
Domain	Transglutaminase_C	TGM1 TGM3	1.99e-04	10	40	2	IPR008958
Domain	TGc	TGM1 TGM3	2.43e-04	11	40	2	SM00460
Domain	Transglut_core	TGM1 TGM3	2.43e-04	11	40	2	PF01841
Domain	Transglutaminase-like	TGM1 TGM3	2.43e-04	11	40	2	IPR002931
Domain	Ig/MHC_CS	SIGLEC14 HLA-DRB4 HLA-DRB5	2.59e-04	58	40	3	IPR003006
Domain	IG_MHC	SIGLEC14 HLA-DRB4 HLA-DRB5	2.86e-04	60	40	3	PS00290
Domain	ABC_A	ABCA13 ABCA7	2.91e-04	12	40	2	IPR026082
Domain	MHC_II_a/b_N	HLA-DRB4 HLA-DRB5	4.00e-04	14	40	2	IPR014745
Domain	-	HLA-DRB4 HLA-DRB5	4.00e-04	14	40	2	3.10.320.10
Domain	Ig_2	SIGLEC14 CD22 LILRB5	5.10e-04	73	40	3	PF13895
Domain	Ig_E-set	TGM1 TGM3 MYCBP2	1.43e-03	104	40	3	IPR014756
Domain	MHC_I/II-like_Ag-recog	HLA-DRB4 HLA-DRB5	2.99e-03	38	40	2	IPR011162
Domain	IG_LIKE	SIGLEC14 CD22 LILRB5 HLA-DRB4 HLA-DRB5	3.79e-03	491	40	5	PS50835
Domain	Ig-like_dom	SIGLEC14 CD22 LILRB5 HLA-DRB4 HLA-DRB5	4.20e-03	503	40	5	IPR007110
Domain	ABC_TRANSPORTER_2	ABCA13 ABCA7	4.74e-03	48	40	2	PS50893
Domain	ABC_tran	ABCA13 ABCA7	4.74e-03	48	40	2	PF00005
Domain	ABC_TRANSPORTER_1	ABCA13 ABCA7	4.94e-03	49	40	2	PS00211
Domain	CUB	DMBT1 CSMD1	4.94e-03	49	40	2	PF00431
Domain	CUB	DMBT1 CSMD1	5.13e-03	50	40	2	SM00042
Domain	ABC_transporter-like	ABCA13 ABCA7	5.13e-03	50	40	2	IPR003439
Domain	Sushi	C2 CSMD1	5.54e-03	52	40	2	PF00084
Domain	-	DMBT1 CSMD1	5.54e-03	52	40	2	2.60.120.290
Domain	CUB	DMBT1 CSMD1	5.75e-03	53	40	2	PS01180
Domain	C1-set	HLA-DRB4 HLA-DRB5	5.97e-03	54	40	2	PF07654
Domain	CCP	C2 CSMD1	5.97e-03	54	40	2	SM00032
Domain	SUSHI	C2 CSMD1	6.40e-03	56	40	2	PS50923
Domain	IGc1	HLA-DRB4 HLA-DRB5	6.40e-03	56	40	2	SM00407
Domain	Sushi_SCR_CCP_dom	C2 CSMD1	6.63e-03	57	40	2	IPR000436
Domain	CUB_dom	DMBT1 CSMD1	6.63e-03	57	40	2	IPR000859
Domain	Ig_C1-set	HLA-DRB4 HLA-DRB5	6.85e-03	58	40	2	IPR003597
Domain	ig	SIGLEC14 CD22 LILRB5	7.77e-03	190	40	3	PF00047
Domain	Immunoglobulin	SIGLEC14 CD22 LILRB5	7.77e-03	190	40	3	IPR013151
Pathway	REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS	CHRM1 CHRM4	5.96e-05	5	35	2	M27300
Pathway	REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS	CHRM1 CHRM4	5.96e-05	5	35	2	MM15006
Pathway	KEGG_HEMATOPOIETIC_CELL_LINEAGE	MME CD22 HLA-DRB4 HLA-DRB5	6.12e-05	87	35	4	M6856
Pathway	BIOCARTA_PEPI_PATHWAY	CELA2B CELA2A	1.25e-04	7	35	2	MM1589
Pathway	BIOCARTA_PEPI_PATHWAY	CELA2B CELA2A	1.66e-04	8	35	2	M22084
Pathway	REACTOME_PROSTANOID_LIGAND_RECEPTORS	TBXA2R PTGER2	2.13e-04	9	35	2	M804
Pathway	REACTOME_PROSTANOID_LIGAND_RECEPTORS	TBXA2R PTGER2	2.13e-04	9	35	2	MM15014
Pathway	BIOCARTA_BBCELL_PATHWAY	HLA-DRB4 HLA-DRB5	3.25e-04	11	35	2	M22030
Pathway	BIOCARTA_EOSINOPHILS_PATHWAY	HLA-DRB4 HLA-DRB5	3.25e-04	11	35	2	M22048
Pathway	BIOCARTA_IL5_PATHWAY	HLA-DRB4 HLA-DRB5	4.59e-04	13	35	2	M18928
Pathway	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	TBXA2R PRSS2 PTGER2 CHRM1 CHRM4	5.21e-04	272	35	5	M13380
Pathway	BIOCARTA_MHC_PATHWAY	HLA-DRB4 HLA-DRB5	5.35e-04	14	35	2	M22023
Pathway	BIOCARTA_BLYMPHOCYTE_PATHWAY	HLA-DRB4 HLA-DRB5	5.35e-04	14	35	2	M1473
Pathway	BIOCARTA_TCRA_PATHWAY	HLA-DRB4 HLA-DRB5	5.35e-04	14	35	2	M10765
Pathway	REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS	TBXA2R PTGER2	5.35e-04	14	35	2	MM15012
Pathway	REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS	TBXA2R PTGER2	6.16e-04	15	35	2	M10620
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES	HLA-DRB4 HLA-DRB5	6.16e-04	15	35	2	M47604
Pathway	BIOCARTA_ASBCELL_PATHWAY	HLA-DRB4 HLA-DRB5	6.16e-04	15	35	2	M7298
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION	HLA-DRB4 HLA-DRB5	6.16e-04	15	35	2	M47588
Pathway	WP_GPCRS_SMALL_LIGAND	TBXA2R PTGER2	8.94e-04	18	35	2	MM15858
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A18 SLC6A14	9.97e-04	19	35	2	MM15107
Pathway	WP_SMALL_LIGAND_GPCRS	TBXA2R PTGER2	9.97e-04	19	35	2	M39728
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A18 SLC6A14	9.97e-04	19	35	2	M27362
Pathway	BIOCARTA_EICOSANOID_PATHWAY	TBXA2R PTGER2	1.11e-03	20	35	2	MM1529
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	TBXA2R PTGER2 CHRM1 CHRM4	1.12e-03	186	35	4	MM15994
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	TGM1 CELA2B CELA2A	1.29e-03	87	35	3	MM15351
Pathway	BIOCARTA_CTLA4_PATHWAY	HLA-DRB4 HLA-DRB5	1.34e-03	22	35	2	M1467
Pathway	BIOCARTA_EICOSANOID_PATHWAY	TBXA2R PTGER2	1.34e-03	22	35	2	M22003
Pathway	BIOCARTA_CSK_PATHWAY	HLA-DRB4 HLA-DRB5	1.34e-03	22	35	2	M6327
Pathway	BIOCARTA_TH1TH2_PATHWAY	HLA-DRB4 HLA-DRB5	1.47e-03	23	35	2	M6705
Pathway	REACTOME_PD_1_SIGNALING	HLA-DRB4 HLA-DRB5	2.17e-03	28	35	2	M18810
Pathway	BIOCARTA_INFLAM_PATHWAY	HLA-DRB4 HLA-DRB5	2.33e-03	29	35	2	M6910
Pathway	KEGG_ASTHMA	HLA-DRB4 HLA-DRB5	2.49e-03	30	35	2	M13950
Pathway	WP_MONOAMINE_GPCRS	CHRM1 CHRM4	2.66e-03	31	35	2	MM15871
Pathway	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	SLC6A18 SLC6A14	2.83e-03	32	35	2	MM14957
Pathway	WP_MONOAMINE_GPCRS	CHRM1 CHRM4	3.01e-03	33	35	2	M39585
Pathway	REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	SLC6A18 SLC6A14	3.01e-03	33	35	2	M188
Pathway	KEGG_ALLOGRAFT_REJECTION	HLA-DRB4 HLA-DRB5	3.78e-03	37	35	2	M18615
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	TBXA2R PTGER2 CHRM1 CHRM4	3.78e-03	260	35	4	M39397
Pathway	WP_GPCRS_NONODORANT	TBXA2R PTGER2 CHRM1 CHRM4	4.10e-03	266	35	4	MM15843
Pathway	REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	HLA-DRB4 HLA-DRB5	4.19e-03	39	35	2	M16523
Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	CD22 HLA-DRB4 HLA-DRB5	4.31e-03	133	35	3	M16476
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-DRB4 HLA-DRB5	4.62e-03	41	35	2	M13519
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	CHRM1 CHRM4	4.84e-03	42	35	2	M5868
Pathway	REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	CHRM1 CHRM4	4.84e-03	42	35	2	MM14971
Pathway	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	C2 HLA-DRB4 HLA-DRB5	4.88e-03	139	35	3	M4741
Pathway	WP_NRF2_PATHWAY	SLC6A18 SLC6A4 SLC6A14	5.07e-03	141	35	3	M39454
Pathway	KEGG_TYPE_I_DIABETES_MELLITUS	HLA-DRB4 HLA-DRB5	5.07e-03	43	35	2	M12617
Pathway	KEGG_ABC_TRANSPORTERS	ABCA13 ABCA7	5.31e-03	44	35	2	M11911
Pathway	WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION	TBXA2R PTGER2	5.54e-03	45	35	2	M39355
Pathway	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	HLA-DRB4 HLA-DRB5	6.29e-03	48	35	2	M615
Pathway	REACTOME_KERATINIZATION	TGM1 CELA2B CELA2A	6.36e-03	153	35	3	MM15343
Pathway	KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY	TBXA2R CHRM1	6.81e-03	50	35	2	M47951
Pathway	KEGG_AUTOIMMUNE_THYROID_DISEASE	HLA-DRB4 HLA-DRB5	7.35e-03	52	35	2	M13103
Pubmed	Sequence organisation and transcriptional regulation of the mouse elastase II and trypsin genes.	PRSS2 CELA2B CELA2A	5.71e-08	7	42	3	3641189
Pubmed	Sequence analysis of three novel DRw14-DRB1 alleles.	HLA-DRB4 HLA-DRB5	1.42e-06	2	42	2	1612646
Pubmed	Differential expression of transglutaminase genes in patients with chronic periodontitis.	TGM1 TGM3	1.42e-06	2	42	2	24112124
Pubmed	Elastase-2, a Tissue Alternative Pathway for Angiotensin II Generation, Plays a Role in Circulatory Sympathovagal Balance in Mice.	CELA2B CELA2A	1.42e-06	2	42	2	28386233
Pubmed	Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.	CHRM1 CHRM4	1.42e-06	2	42	2	26958838
Pubmed	Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans.	CELA2B CELA2A	1.42e-06	2	42	2	16327289
Pubmed	Ectopic transglutaminase 1 and 3 expression accelerating keratinization in oral lichen planus.	TGM1 TGM3	1.42e-06	2	42	2	30213231
Pubmed	Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.	CHRM1 CHRM4	1.42e-06	2	42	2	34806612
Pubmed	Identification of two novel HLA-DRB1 alleles, DRB10903 and DRB11145.	HLA-DRB4 HLA-DRB5	1.42e-06	2	42	2	15191532
Pubmed	Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium.	TGM1 TGM3	1.42e-06	2	42	2	14645372
Pubmed	Detection of four novel alleles: DRB11130, DRB113072, DRB11315 and DRB11331.	HLA-DRB4 HLA-DRB5	1.42e-06	2	42	2	10703621
Pubmed	Investigation of mouse amniotic fluid for stimulating ability of keratinocyte differentiation depending on the fetal stage.	TGM1 TGM3	1.42e-06	2	42	2	34390735
Pubmed	Characterization of pancreatic elastase II cDNAs: two elastase II mRNAs are expressed in human pancreas.	CELA2B CELA2A	1.42e-06	2	42	2	3646943
Pubmed	Characterization of three HLA-DR beta genes isolated from an HLA-DR 3/4 insulin-dependent diabetic patient.	HLA-DRB4 HLA-DRB5	1.42e-06	2	42	2	3015788
Pubmed	Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.	CHRM1 CHRM4	1.42e-06	2	42	2	12476323
Pubmed	Two DR2-associated novel alleles arose from the silent mutation of codon 72: DRB116012, DRB501012.	HLA-DRB4 HLA-DRB5	1.42e-06	2	42	2	10551425
Pubmed	The repertoire of solute carriers of family 6: identification of new human and rodent genes.	SLC6A18 SLC6A4 SLC6A14	2.15e-06	21	42	3	16125675
Pubmed	Complete cDNA sequences of the HLA-DRB10402 and DRB111041 alleles.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	12358860
Pubmed	SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.	TGM1 TGM3	4.27e-06	3	42	2	15304086
Pubmed	Mhc-DRB diversity of the chimpanzee (Pan troglodytes).	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	1428007
Pubmed	Direct sequencing of SSP-PCR-amplified cDNA to identify new alleles in the DR52-associated DRB1 group: identification of DRB11115, DRB11117 and DRB1*1319.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	7652736
Pubmed	Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.	TBXA2R PTGER2	4.27e-06	3	42	2	24085850
Pubmed	Assignment of muscarinic receptor subtypes mediating G-protein modulation of Ca(2+) channels by using knockout mice.	CHRM1 CHRM4	4.27e-06	3	42	2	10485923
Pubmed	Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	2023919
Pubmed	Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice.	CHRM1 CHRM4	4.27e-06	3	42	2	28442355
Pubmed	Genetic variation in the epidermal transglutaminase genes is not associated with atopic dermatitis.	TGM1 TGM3	4.27e-06	3	42	2	23189155
Pubmed	Recent origin of HLA-DRB1 alleles and implications for human evolution.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	9500545
Pubmed	A novel DRB1*09 allelic sequence in the Jing ethnic minority of China.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	12121280
Pubmed	HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	19811438
Pubmed	Diversity associated with the second expressed HLA-DRB locus in the human population.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	9162096
Pubmed	Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	3099214
Pubmed	Gene disruption of tissue transglutaminase.	TGM1 TGM3	4.27e-06	3	42	2	11113189
Pubmed	Hornerin is a component of the epidermal cornified cell envelopes.	TGM1 TGM3	4.27e-06	3	42	2	21282207
Pubmed	No gender differences in the frequencies of HLA-DRB3/B4/B5 heterozygotes in newborns and adults in Koreans.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	22531795
Pubmed	A novel HLA-DRB109 allele, HLA-DRB1090103*, isolated from the Han population of Guangdong, China.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	15730527
Pubmed	Primary structure of human pancreatic elastase 2 determined by sequence analysis of the cloned mRNA.	CELA2B CELA2A	4.27e-06	3	42	2	3427074
Pubmed	[Association of hemorrhagic fever with renal syndrome and HLA-DRB allele polymorphisms in Han nationality, Hubei province].	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	20193583
Pubmed	Shared class II MHC polymorphisms between humans and chimpanzees.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	2511168
Pubmed	Thromboxane A2 induces blood flow recovery via platelet adhesion to ischaemic regions.	TBXA2R PTGER2	4.27e-06	3	42	2	25935870
Pubmed	Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias.	CHRM1 CHRM4	4.27e-06	3	42	2	18282687
Pubmed	Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.	TGM1 TGM3	4.27e-06	3	42	2	15715085
Pubmed	Low prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis.	TGM1 TGM3	4.27e-06	3	42	2	24885370
Pubmed	Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica Obliterans.	TGM1 TGM3	4.27e-06	3	42	2	27649154
Pubmed	Identification of a novel HLA-DRB109 allele, DRB10904, in the Korean population, by sequence-based typing.	HLA-DRB4 HLA-DRB5	4.27e-06	3	42	2	16441501
Pubmed	Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.	SIGLEC14 CD22	8.53e-06	4	42	2	17562860
Pubmed	Allelic variation in the DR subregion of the human major histocompatibility complex.	HLA-DRB4 HLA-DRB5	8.53e-06	4	42	2	3476943
Pubmed	TGM1/3-mediated transamidation of Exo70 promotes tumor metastasis upon LKB1 inactivation.	TGM1 TGM3	8.53e-06	4	42	2	39146185
Pubmed	Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.	HLA-DRB4 HLA-DRB5	8.53e-06	4	42	2	26740600
Pubmed	Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes.	CHRM1 CHRM4	8.53e-06	4	42	2	11855742
Pubmed	Muscarinic receptor subtypes. Physiology and clinical implications.	CHRM1 CHRM4	8.53e-06	4	42	2	2674717
Pubmed	Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes.	CHRM1 CHRM4	8.53e-06	4	42	2	2739737
Pubmed	Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia.	CHRM1 CHRM4	8.53e-06	4	42	2	35314320
Pubmed	Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors.	CHRM1 CHRM4	8.53e-06	4	42	2	9603968
Pubmed	Identification of a family of muscarinic acetylcholine receptor genes.	CHRM1 CHRM4	8.53e-06	4	42	2	3037705
Pubmed	Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.	CHRM1 CHRM4	8.53e-06	4	42	2	15147302
Pubmed	Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype.	HLA-DRB4 HLA-DRB5	8.53e-06	4	42	2	3020127
Pubmed	Ciliary activity in the oviduct of cycling, pregnant, and muscarinic receptor knockout mice.	CHRM1 CHRM4	8.53e-06	4	42	2	22302687
Pubmed	HLA-DRB alleles and systemic lupus erythematosus in Jamaicans.	HLA-DRB4 HLA-DRB5	8.53e-06	4	42	2	12144077
Pubmed	Transglutaminase and clusterin induction during normal and abnormal limb development in the mouse.	TGM1 TGM3	8.53e-06	4	42	2	8828830
Pubmed	Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort.	HLA-DRB4 HLA-DRB5	8.53e-06	4	42	2	18520346
Pubmed	Two divergent routes of evolution gave rise to the DRw13 haplotypes.	HLA-DRB4 HLA-DRB5	8.53e-06	4	42	2	2212675
Pubmed	Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice.	TGM1 TGM3	8.53e-06	4	42	2	16465267
Pubmed	Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death.	TGM1 TGM3	8.53e-06	4	42	2	9511731
Pubmed	Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.	CHRM1 CHRM4	8.53e-06	4	42	2	3443095
Pubmed	M(1)/M(3) and M(2)/M(4) muscarinic receptor double-knockout mice present distinct respiratory phenotypes.	CHRM1 CHRM4	8.53e-06	4	42	2	18206430
Pubmed	Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice.	CHRM1 CHRM4	1.42e-05	5	42	2	20940295
Pubmed	Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction.	SLC6A4 CHRM1	1.42e-05	5	42	2	19494266
Pubmed	Muscarinic acetylcholine receptor subtype 4 is essential for cholinergic stimulation of duodenal bicarbonate secretion in mice - relationship to D cell/somatostatin.	CHRM1 CHRM4	1.42e-05	5	42	2	26084221
Pubmed	Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice.	CHRM1 CHRM4	1.42e-05	5	42	2	15919709
Pubmed	Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.	CHRM1 CHRM4	1.42e-05	5	42	2	12675128
Pubmed	Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway.	CHRM1 CHRM4	1.42e-05	5	42	2	15913791
Pubmed	Muscarinic acetylcholine receptor subtypes: localization and structure/function.	CHRM1 CHRM4	1.42e-05	5	42	2	8248499
Pubmed	NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	11782380
Pubmed	Antinuclear antibodies and HLA class II alleles in Jamaican patients with systemic lupus erythematosus.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	17910142
Pubmed	The M1 muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice.	CHRM1 CHRM4	1.42e-05	5	42	2	30914695
Pubmed	Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice.	CHRM1 CHRM4	1.42e-05	5	42	2	15661360
Pubmed	Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	16973583
Pubmed	Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention.	CD22 MCOLN1	1.42e-05	5	42	2	29617956
Pubmed	Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	1970352
Pubmed	Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	7645219
Pubmed	Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.	CHRM1 CHRM4	1.42e-05	5	42	2	27618677
Pubmed	A comparison of HLA-DR and -DQ allele and haplotype frequencies in Trinidadian populations of African, South Asian, and mixed ancestry.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	12392858
Pubmed	Differential regulation of primary afferent input to spinal cord by muscarinic receptor subtypes delineated using knockout mice.	CHRM1 CHRM4	1.42e-05	5	42	2	24695732
Pubmed	Muscarinic receptors in the prenatal mouse embryo. Comparison of M35-immunohistochemistry with [3H]quinuclidinyl benzylate autoradiography.	CHRM1 CHRM4	1.42e-05	5	42	2	7648406
Pubmed	Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase).	TGM1 TGM3	1.42e-05	5	42	2	9448282
Pubmed	Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum.	CHRM1 CHRM4	1.42e-05	5	42	2	15574798
Pubmed	HLA-DQ8 and the HLA-DQ8-DR4 haplotype are positively associated with the hevein-specific IgE immune response in health care workers with latex allergy.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	12209103
Pubmed	Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease.	ABCA7 HLA-DRB5	1.42e-05	5	42	2	25365775
Pubmed	Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	23152536
Pubmed	HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	17411376
Pubmed	Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart.	CHRM1 CHRM4	1.42e-05	5	42	2	11306684
Pubmed	Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	17507489
Pubmed	Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity.	CHRM1 CHRM4	1.42e-05	5	42	2	20197056
Pubmed	Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	7734415
Pubmed	Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.	CHRM1 CHRM4	1.42e-05	5	42	2	12151512
Pubmed	Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback.	CHRM1 CHRM4	1.42e-05	5	42	2	29401598
Pubmed	Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development.	CHRM1 CHRM4	1.42e-05	5	42	2	19213795
Pubmed	The role of muscarinic receptor subtypes in acetylcholine release from urinary bladder obtained from muscarinic receptor knockout mouse.	CHRM1 CHRM4	1.42e-05	5	42	2	18755247
Pubmed	Visual hallucinations and HLA class II antigens in cortical dementia.	HLA-DRB4 HLA-DRB5	1.42e-05	5	42	2	20606439
Pubmed	Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing.	CELA2B CELA2A	1.42e-05	5	42	2	20179351
Cytoband	19q13.4	SIGLEC14 CACNG6 LILRB5	5.36e-05	79	42	3	19q13.4
Cytoband	1p36.21	CELA2B CELA2A	1.54e-03	63	42	2	1p36.21
Cytoband	6p21.3	C2 HLA-DRB4 HLA-DRB5	1.57e-03	250	42	3	6p21.3
GeneFamily	Cholinergic receptors muscarinic	CHRM1 CHRM4	2.84e-05	5	31	2	180
GeneFamily	Transglutaminases	TGM1 TGM3	1.02e-04	9	31	2	773
GeneFamily	Prostaglandin (prostanoid) receptors	TBXA2R PTGER2	1.02e-04	9	31	2	207
GeneFamily	ATP binding cassette subfamily A	ABCA13 ABCA7	2.56e-04	14	31	2	805
GeneFamily	CD molecules\|C2-set domain containing\|Sialic acid binding Ig like lectins	SIGLEC14 CD22	1.05e-03	28	31	2	745
GeneFamily	C1-set domain containing	HLA-DRB4 HLA-DRB5	2.35e-03	42	31	2	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-DRB4 HLA-DRB5	2.57e-03	44	31	2	588
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	C2 CSMD1	4.28e-03	57	31	2	1179
Coexpression	NABA_MATRISOME_HYPERPLASTIC_PANCREATIC_ISLETS	PRSS2 CELA2B DMBT1 CELA2A	6.78e-08	26	40	4	MM17051
Coexpression	VILIMAS_NOTCH1_TARGETS_DN	CELA2B LILRB5 CELA2A	1.91e-05	34	40	3	MM791
Coexpression	BERGER_MBD2_TARGETS	PRSS2 CELA2A	2.26e-05	5	40	2	M2296
Coexpression	NABA_ECM_REGULATORS	TGM1 TGM3 PRSS2 CELA2B CELA2A	3.00e-05	238	40	5	M3468
Coexpression	NABA_ECM_REGULATORS	TGM1 TGM3 PRSS2 CELA2B CELA2A	3.25e-05	242	40	5	MM17062
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL	C2 TNFRSF25 LILRB5	5.43e-05	48	40	3	M45740
Coexpression	TABULA_MURIS_SENIS_PANCREAS_LEUKOCYTE_AGEING	PRSS2 CELA2B CELA2A	6.14e-05	50	40	3	MM3814
Coexpression	FOSTER_KDM1A_TARGETS_UP	CRYBG1 CELA2B DCSTAMP HLA-DRB5 CELA2A	1.17e-04	317	40	5	MM956
Coexpression	BERGER_MBD2_TARGETS	CELA2B CELA2A	1.24e-04	11	40	2	MM905
CoexpressionAtlas	lung	SLC6A4 C2 CHIA DCSTAMP SLC6A14 HLA-DRB5	9.42e-07	182	39	6	lung
ToppCell	390C-Myeloid-Macrophage\|390C / Donor, Lineage, Cell class and subclass (all cells)	MME CELA2B MCOLN1 LILRB5 HLA-DRB5	8.44e-07	190	41	5	f933d971f092c4e56e9f670a9205b688c8b1ca28
ToppCell	390C-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	C2 MME MCOLN1 LILRB5 HLA-DRB5	9.59e-07	195	41	5	ba494be431916d43c1d480f65bed674c0722c710
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C2 MME CELA2B MCOLN1 HLA-DRB5	9.84e-07	196	41	5	eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26
ToppCell	Serous\|World / shred by cell class for turbinate	DMBT1 CHRM1 CNGA1 PGBD3	1.09e-05	150	41	4	6a326662d58b0f17d6efa8cc28571f4cbbf57c2d
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGM3 PRSS2 CHIA CELA2A	1.12e-05	151	41	4	a306e8dac653bc785d805d8d2d94feec3cb01727
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGM3 DMBT1 ABCA13 CNGA1	1.48e-05	162	41	4	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	CERCAM CACNG6 PTGER2 HLA-DRB5	1.55e-05	164	41	4	60fe6bb86afaebd92590135f08f5434ce0d8d73c
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CRYBG1 TNFRSF25 TDRD9 PTGER2	1.63e-05	166	41	4	000faacc79b0bd279ddce4e692d801e7e2063ab6
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGM1 PRSS2 DMBT1 CELA2A	1.63e-05	166	41	4	b7f303203068b205f382788815df487a0ea148ed
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 PTGER2 MCOLN1 CELA2A	2.00e-05	175	41	4	3bca1aac2a2a1f46753b5f9462888f144ed8327b
ToppCell	Bronchial_Biopsy-Immune-Luminal_Macrophages\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	SIGLEC14 MME CELA2B DCSTAMP	2.00e-05	175	41	4	1cf99de391552d4f8dbe2ed5b01fc3b8adca61b6
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 TDRD9 MYCBP2 CELA2A	2.05e-05	176	41	4	feafc757e7aa4f17128ff34886beb2fd3461c9ea
ToppCell	facs-Heart-LA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CD22 CELA2A	2.05e-05	176	41	4	077f3fe5e3482ea3f639d789bd3d584161b36c02
ToppCell	3'_v3-GI_small-bowel-Myeloid_Mac-Macrophage\|GI_small-bowel / Manually curated celltypes from each tissue	SIGLEC14 C2 MME DCSTAMP	2.05e-05	176	41	4	4be270f6bb7da4070f972aca403109751646d155
ToppCell	facs-Heart-LA-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CD22 CELA2A	2.05e-05	176	41	4	fc2ba468677b19b55130c1f06737f40300cd9d2e
ToppCell	wk_15-18-Hematologic-Myeloid-APOE+_Mac2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	C2 MCOLN1 LILRB5 HLA-DRB5	2.24e-05	180	41	4	c630a121aedd09a51ea18cc6e8552eb979e5b555
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac\|Myeloid_cells / Location, Cell class and cell subclass	C2 MME DCSTAMP HLA-DRB5	2.33e-05	182	41	4	a035d45fd512bee8dac38eb387dbf39f5a8a1fed
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 MME DMBT1 CELA2A	2.59e-05	187	41	4	9aa411ae9b5a923378a5daebb8bb2fc2613f2510
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNFRSF25 MCOLN1 LILRB5 HLA-DRB5	2.59e-05	187	41	4	39b99f46b723f7f3c44880d7fe8642cbad558b8a
ToppCell	368C-Myeloid-Macrophage\|368C / Donor, Lineage, Cell class and subclass (all cells)	C2 MME MCOLN1 HLA-DRB5	2.71e-05	189	41	4	e62355be0d136e2b7c739848022292e9c6af7392
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SIGLEC14 C2 MCOLN1 HLA-DRB5	2.71e-05	189	41	4	6cdd743bc46e34dc48288dda343309131b6c2d5f
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Mac\|lymph-node_spleen / Manually curated celltypes from each tissue	C2 MME DCSTAMP LILRB5	2.71e-05	189	41	4	aac79c41ce7acba722c45c016b2c6997fb772a96
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	C2 DCSTAMP MCOLN1 LILRB5	2.76e-05	190	41	4	96c6078619e85f630c9754aca5d6066433e22836
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	MME CELA2B DCSTAMP MCOLN1	2.76e-05	190	41	4	4cce4ddb79b7751d0103e10f71156977e0c34439
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	C2 CNGA1 LILRB5 HLA-DRB5	2.88e-05	192	41	4	935a4a36881a9fa4daa02cba96af07f6686ed8d6
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-Tuft-related\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SH2D6 DMBT1 CSMD1 ABCA13	2.88e-05	192	41	4	d6ea34391c3f730684b82e912d9cf55e928b3311
ToppCell	390C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	C2 MME CELA2B MCOLN1	2.94e-05	193	41	4	c9cf5a661294a947d06d53d18d47362c0e0b6ef5
ToppCell	facs-Pancreas-Exocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 MME DMBT1 CELA2A	2.94e-05	193	41	4	c3161a14a40323a58aa202c8a1d6ea0e9c2b9814
ToppCell	myeloid-macrophage\|World / Lineage and Cell class	C2 MCOLN1 LILRB5 HLA-DRB5	2.94e-05	193	41	4	b13e694123b87ed8ad1786feb996398ddd84e94b
ToppCell	356C-Myeloid-Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	MME DCSTAMP MCOLN1 HLA-DRB5	3.00e-05	194	41	4	3844e6fb43ae2e0a35ea8ccc1a2e11f40b68bc67
ToppCell	343B-Myeloid-Macrophage\|343B / Donor, Lineage, Cell class and subclass (all cells)	MME DCSTAMP MCOLN1 HLA-DRB5	3.06e-05	195	41	4	48ba2044d2459c8b0d17bc7deca8d0195ac6a00e
ToppCell	(7)_Epithelial-A_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	C2 CHIA DMBT1 SLC6A14	3.06e-05	195	41	4	c9a6c65ee18d83bf34a4713d306a6e30db1325c2
ToppCell	(7)_MNP-(7)_Macrophage\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	C2 CD22 MCOLN1 LILRB5	3.12e-05	196	41	4	71ec157163278ad259c190051926bf41e4ecef46
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	C2 DCSTAMP MCOLN1 LILRB5	3.12e-05	196	41	4	bd2c2de103e28b65ea537c22f71225cb0deef1e0
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C2 MME CELA2B HLA-DRB5	3.12e-05	196	41	4	173d2c38a01c9ae1c50657d5fc383238aed4aacb
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	C2 DCSTAMP MCOLN1 LILRB5	3.12e-05	196	41	4	072a4150ae521c6589b0f7cd60e975fb33715bf4
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C2 MME CELA2B HLA-DRB5	3.12e-05	196	41	4	2793ad692d49b3ee78a5cd2d8e0220bf5188a686
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C2 MME CELA2B HLA-DRB5	3.12e-05	196	41	4	aae79eafe5bc2c7de16958994a2fe97439d7bea1
ToppCell	(7)_Macrophage\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	C2 MCOLN1 LILRB5 HLA-DRB5	3.12e-05	196	41	4	f1c822860d2a0bae84b0263b0151185756423e0f
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIGLEC14 C2 LILRB5 HLA-DRB5	3.18e-05	197	41	4	67bf15ee83938bd40f6ecd5abaaf90ad95096d21
ToppCell	343B-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	C2 MME MCOLN1 HLA-DRB5	3.18e-05	197	41	4	1b6f7a62b7fcfd55c25c5840353eed7183050860
ToppCell	Bronchus_Control_(B.)-Immune-TX-TRAM-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	C2 MME CELA2B LILRB5	3.18e-05	197	41	4	eecb693367510da20a6b1e9355e68785a1e3b85c
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Htr1a_(Neuron.Slc17a6.Htr1a)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TGM3 DCSTAMP SLC6A14	3.23e-05	67	41	3	be6853b5bf254063f02a4c478fd4c3fef68cb77a
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Htr1a_(Neuron.Slc17a6.Htr1a)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TGM3 DCSTAMP SLC6A14	3.23e-05	67	41	3	7483b85423d9d07b01b60927d0fe1b7ccb241d7f
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MME DCSTAMP LILRB5 HLA-DRB5	3.31e-05	199	41	4	98c0d57c247d39bc771d81f4387f8dd01222628e
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	C2 DMBT1 ABCA7 SLC6A14	3.31e-05	199	41	4	7ebd89dff457f57a549eecee288c7a4b515b4018
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	C2 DCSTAMP MCOLN1 LILRB5	3.31e-05	199	41	4	980b10b81ee9dc952e3be25bd294201ce5a4ca8b
ToppCell	10x5'-Liver-Myeloid_Mac-Erythrophagocytic_macrophages\|Liver / Manually curated celltypes from each tissue	C2 MCOLN1 LILRB5 HLA-DRB5	3.31e-05	199	41	4	600afac424416268766fc5c051d4c62ab9eef5de
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	C2 DCSTAMP MCOLN1 LILRB5	3.31e-05	199	41	4	cbd423c31d75f6d2f5ae85d2241641fcbe630b81
ToppCell	ASK454-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	C2 DMBT1 SLC6A14 HLA-DRB5	3.31e-05	199	41	4	cbfabf8e895abe454606b990f99e3738f4263ffe
ToppCell	wk_15-18-Hematologic-Myeloid-SPP1+_Mac\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	C2 MCOLN1 LILRB5 HLA-DRB5	3.31e-05	199	41	4	c7fc2ac1601346aac71e7620a8a440fde8d92dbd
ToppCell	10x5'-Liver-Myeloid_Mac\|Liver / Manually curated celltypes from each tissue	C2 MCOLN1 LILRB5 HLA-DRB5	3.31e-05	199	41	4	aed138ee879e4e625f177c5bfe0f857a335eb6f2
ToppCell	Biopsy_IPF-Epithelial-AT2\|Biopsy_IPF / Sample group, Lineage and Cell type	C2 CHIA DMBT1 SLC6A14	3.31e-05	199	41	4	c841d475703d3489161fb7904526bd7563d5fb0f
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MME DCSTAMP MCOLN1 HLA-DRB5	3.37e-05	200	41	4	980cb0390586d8312890e8d0f3cf58e3309d16c5
ToppCell	10x5'-Lung-Myeloid_Mac-Alveolar_macrophages\|Lung / Manually curated celltypes from each tissue	C2 MME MCOLN1 HLA-DRB5	3.37e-05	200	41	4	3b236900df407bf5a8c44e76d003a7a37d251db6
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	C2 CHIA DMBT1 SLC6A14	3.37e-05	200	41	4	65c83a3f6ee2a10bcb5b95076696232c6373a7b4
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	C2 CHIA DMBT1 SLC6A14	3.37e-05	200	41	4	40e969883bc302e8fbc6b6ab9814529dc1472902
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT2-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	C2 CHIA DMBT1 SLC6A14	3.37e-05	200	41	4	ad9cdc82a647d379abc713a56db0e11bb6494106
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MME DCSTAMP MCOLN1 HLA-DRB5	3.37e-05	200	41	4	d7d971586c01152b3d21956fd98280588cb8f08b
ToppCell	droplet-Pancreas-Exocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 DMBT1 CELA2A	3.69e-05	70	41	3	26178ee967d647224d93c7a6380f2d15d8fcfb8f
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 DMBT1 CELA2A	3.69e-05	70	41	3	5720505ef03d65c73028616c808420e282823bde
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 DMBT1 CELA2A	9.76e-05	97	41	3	16947da747504c2edb9f2e7ee6f05babda0fae60
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 DMBT1 CELA2A	1.27e-04	106	41	3	3aa55c3db4e4abd39c8f2f89f2516927d94ad9d7
ToppCell	droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 DMBT1 CELA2A	1.27e-04	106	41	3	c890c838785dfeda30f3b563194da9cfb49b157a
ToppCell	TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Testicular_Germ_Cell_Tumor-4\|TCGA-Testes / Sample_Type by Project: Shred V9	CHIA DMBT1 SLC6A14	1.49e-04	112	41	3	3ec029eac64247c5e48074dad5c71df690e84f4c
ToppCell	droplet-Skin-nan-18m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGM1 TGM3 CHRM1	2.32e-04	130	41	3	4c8b931987432e8bcd39029d4fa124dc383ea355
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 DMBT1 CELA2A	2.48e-04	133	41	3	91e4556658e49f92946d48b194df64c5fc5758fe
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A4 CHIA DMBT1	2.53e-04	134	41	3	45c0cccca133ffc261ba45271d72b21f5402ec3c
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac\|Myeloid_cells / Location, Cell class and cell subclass	MME CELA2B DCSTAMP	2.94e-04	141	41	3	399380de5ea09e22fd128e3e55fffeffc4874c15
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MME ABCA13 LILRB5	3.01e-04	142	41	3	191a13bba143ecdfc2bfd797c3ac191481388298
ToppCell	COVID-19_Mild-Myeloid_G\|COVID-19_Mild / Disease group, lineage and cell class	CACNG6 MME ABCA13	3.01e-04	142	41	3	c8aeb747ed836197265d269aa131fae172b45aec
ToppCell	mild_COVID-19-B_cell\|World / disease group, cell group and cell class (v2)	MME CD22 HLA-DRB5	3.07e-04	143	41	3	4698cc877dda9b1ef7d6f18c9adc869ef791b1d8
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	C2 DCSTAMP HLA-DRB5	3.07e-04	143	41	3	4c5a5db46beb8f2f3c40e8ed95911fbfea61bae0
ToppCell	PBMC-Mild-Myeloid-Neutrophil\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	CACNG6 MME ABCA13	3.07e-04	143	41	3	974260c25dad599eea83a33e83117f7307b92a42
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MME ABCA13 LILRB5	3.07e-04	143	41	3	b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	3.33e-04	147	41	3	9bc4185920b2b0f1fd5c6e2ec5583b9cd49c2efd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A4 CRYBG1 CNGA1	3.33e-04	147	41	3	64fa0753a3a79f492ef8acc6942bf90d379a983f
ToppCell	Bronchus_Control_(B.)-Immune-TX-TRAM-3\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	SH2D6 CD22 HLA-DRB5	3.33e-04	147	41	3	50a855aa7f214c3be8ac46a22adf9bc9dd0285db
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	3.33e-04	147	41	3	9b0f87a6dd5224c2b06deafeae04a1b04e53eb75
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNFRSF25 CELA2B FAM120C	3.53e-04	150	41	3	53de595376a9fc92491dfd58ff25938b0bf79903
ToppCell	TCGA-Lung\|World / Sample_Type by Project: Shred V9	CHIA ABCA13 SLC6A14	3.53e-04	150	41	3	8c133206786e8f22bb70f2a7de9c0cb7f9ea9313
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNFRSF25 CELA2B FAM120C	3.53e-04	150	41	3	e4b40b3243ed26d0c46bf196ac06e148834e7ed2
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TGM1 MME CELA2B	3.67e-04	152	41	3	7a1072315cce71eefe2d32149a107d5648999968
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C2 TGM3 PTGER2	3.74e-04	153	41	3	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 DMBT1 CELA2A	3.74e-04	153	41	3	39ac25c48e73538f1c10f37bea386e0e88d3e8d0
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	3.81e-04	154	41	3	c6f1a0806d492b1f01cded2daffaf3f13422deb6
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TGM1 TNFRSF25 SLC6A14	3.81e-04	154	41	3	8a643d91896af9b630a715fb284c1523d01ad1a3
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	3.81e-04	154	41	3	665885d8aca168513ab7a65f70d52181c821eb78
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	3.81e-04	154	41	3	3c64111e2ca1bb04ddd1ecb19938a307778ff7eb
ToppCell	AT1-AT2_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	SLC6A4 DMBT1 SLC6A14	3.88e-04	155	41	3	010e45ef4b505bf419ea41e4d1619521d1c78319
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	MME CELA2B DCSTAMP	3.88e-04	155	41	3	03fd443740272dcb547e39deaf7ae89b8307f241
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	MME CELA2B CELA2A	3.96e-04	156	41	3	1a0e081284a99c1b345990775015b8a2fa469496
ToppCell	facs-Skin-Telogen-3m-Epithelial-inner_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBXA2R CHIA CD22	3.96e-04	156	41	3	ba9dfee9373d657d2a55572b41fc62001ad8b037
ToppCell	facs-MAT-Fat-24m\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	3.96e-04	156	41	3	7433c6d4eb4d061844d8979c1e648d8ed56e1073
ToppCell	Smart-seq2-thymus_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DCSTAMP MYCBP2 CELA2A	3.96e-04	156	41	3	cea7b4f133272499e77ed451db91f699cff6a4bb
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNFRSF25 FAM120C HLA-DRB5	3.96e-04	156	41	3	a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6
ToppCell	facs-MAT-Fat-24m-Epithelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	4.03e-04	157	41	3	30814ff90cead688ef64dac4cf4a6d63756d8944
ToppCell	facs-MAT-Fat-24m-Epithelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	4.03e-04	157	41	3	a47d102570e82d34ea1a8756f82636e7ab27c07f
ToppCell	facs-MAT-Fat-24m-Epithelial-epithelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS2 CHIA CELA2A	4.03e-04	157	41	3	7c20f225b2db8b340f4fec050ff29e666b860f04
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TDRD9 CNGA1 CHRM4	4.18e-04	159	41	3	4750ba9ca06ed97b18df3c74eeb51d3ac8763f63
Computational	Serine proteases.	C2 PRSS2 CELA2B CELA2A	2.09e-06	39	26	4	MODULE_109
Computational	Neighborhood of SERPINI2	PRSS2 CELA2B CELA2A	2.79e-05	25	26	3	GNF2_SERPINI2
Computational	Genes in the cancer module 293.	HLA-DRB4 HLA-DRB5	3.66e-04	12	26	2	MODULE_293
Computational	Genes in the cancer module 143.	HLA-DRB4 HLA-DRB5	5.03e-04	14	26	2	MODULE_143
Drug	Paroxetine	SLC6A4 CHRM1 CHRM4	3.02e-07	8	41	3	DB00715
Drug	Imipramine	SLC6A4 CHRM1 CHRM4	8.85e-07	11	41	3	DB00458
Drug	Nortriptyline	SLC6A4 CHRM1 CHRM4	1.18e-06	12	41	3	DB00540
Drug	Desipramine	SLC6A4 CHRM1 CHRM4	1.53e-06	13	41	3	DB01151
Drug	Amitriptyline	SLC6A4 CHRM1 CHRM4	4.34e-06	18	41	3	DB00321
Drug	8-iso Misoprostol	TBXA2R PLCD4 PRSS2 PTGER2	4.68e-06	62	41	4	CID004183806
Drug	Doxepin	SLC6A4 CHRM1 CHRM4	6.05e-06	20	41	3	DB01142
Drug	5-chlorohydroxyquinol	TGM1 C2	9.48e-06	3	41	2	CID000189666
Drug	(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride	CHRM1 CHRM4	9.48e-06	3	41	2	ctd:D008455
Drug	RS-61756-007	TBXA2R PTGER2	9.48e-06	3	41	2	CID006439093
Drug	iprindole	SLC6A4 MME CHRM1	1.72e-05	28	41	3	CID000021722
Drug	furtrethonium	CHRM1 CHRM4	1.89e-05	4	41	2	ctd:C028530
Drug	Hyoscyamine	CHRM1 CHRM4	1.89e-05	4	41	2	DB00424
Drug	Procyclidine	CHRM1 CHRM4	1.89e-05	4	41	2	DB00387
Drug	5-methylfurtrethonium	CHRM1 CHRM4	1.89e-05	4	41	2	ctd:C008446
Drug	WIN 62577	CHRM1 CHRM4	1.89e-05	4	41	2	ctd:C086110
Drug	WIN 51708	CHRM1 CHRM4	1.89e-05	4	41	2	ctd:C086111
Drug	AC1L1HNG	TBXA2R PTGER2	1.89e-05	4	41	2	CID000004206
Drug	Tropicamide	CHRM1 CHRM4	1.89e-05	4	41	2	DB00809
Drug	Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A	CRYBG1 TNFRSF25 CD22 FAM120C SLC6A14	2.04e-05	186	41	5	3902_DN
Drug	AC1MO44G	TBXA2R TGM1 MME CHRM1	2.25e-05	92	41	4	CID003363161
Drug	Butamben [94-25-7]; Up 200; 20.6uM; PC3; HT_HG-U133A	TBXA2R TNFRSF25 DMBT1 FAM120C CNGA1	2.68e-05	197	41	5	5792_UP
Drug	Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A	SLC6A4 TNFRSF25 CD22 FAM120C ABCA7	2.75e-05	198	41	5	4844_UP
Drug	Atropine	CHRM1 CHRM4	3.15e-05	5	41	2	DB00572
Drug	Fesoterodine	CHRM1 CHRM4	3.15e-05	5	41	2	DB06702
Drug	Darifenacin	CHRM1 CHRM4	3.15e-05	5	41	2	DB00496
Drug	Metixene	CHRM1 CHRM4	3.15e-05	5	41	2	DB00340
Drug	Trihexyphenidyl	CHRM1 CHRM4	3.15e-05	5	41	2	DB00376
Drug	Solifenacin	CHRM1 CHRM4	3.15e-05	5	41	2	DB01591
Drug	Scopolamine Derivatives	CHRM1 CHRM4	3.15e-05	5	41	2	ctd:D012602
Drug	5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide	CHRM1 CHRM4	3.15e-05	5	41	2	ctd:C568516
Drug	8-acetyl-12-hydroxyheptadecanoic acid	TBXA2R PTGER2	3.15e-05	5	41	2	CID012042400
Drug	xanomeline	CHRM1 CHRM4	3.15e-05	5	41	2	ctd:C075257
Drug	Pipecuronium	CHRM1 CHRM4	3.15e-05	5	41	2	ctd:D017300
Drug	N-Methylscopolamine	CHRM1 CHRM4	3.15e-05	5	41	2	ctd:D019832
Drug	Tolterodine	CHRM1 CHRM4	3.15e-05	5	41	2	DB01036
Drug	Cryptenamine	CHRM1 CHRM4	3.15e-05	5	41	2	DB00785
Drug	Homatropine Methylbromide	CHRM1 CHRM4	3.15e-05	5	41	2	DB00725
Drug	enediyne antibiotics	SLC6A4 CHRM1	3.15e-05	5	41	2	CID005378630
Drug	Quinuclidinyl Benzilate	CHRM1 CHRM4	3.15e-05	5	41	2	ctd:D011813
Drug	2-methylvalerate	C2 CS	4.72e-05	6	41	2	CID000007341
Drug	Gallamine Triethiodide	CHRM1 CHRM4	4.72e-05	6	41	2	ctd:D005703
Drug	Escitalopram	SLC6A4 CHRM1	4.72e-05	6	41	2	DB01175
Drug	octacosane	C2 CHIA	4.72e-05	6	41	2	CID000012408
Drug	brucine N-oxide	CHRM1 CHRM4	4.72e-05	6	41	2	ctd:C083067
Drug	Brompheniramine	CHRM1 CHRM4	4.72e-05	6	41	2	DB00835
Drug	Benzquinamide	CHRM1 CHRM4	4.72e-05	6	41	2	DB00767
Drug	Scopolamine	CHRM1 CHRM4	4.72e-05	6	41	2	DB00747
Drug	Crotalid Venoms	CHRM1 CHRM4	4.72e-05	6	41	2	ctd:D003435
Drug	Palladium	HLA-DRB4 HLA-DRB5	6.61e-05	7	41	2	ctd:D010165
Drug	Tiotropium Bromide	CHRM1 CHRM4	6.61e-05	7	41	2	ctd:D000069447
Drug	Amoxapine	SLC6A4 CHRM1	8.80e-05	8	41	2	DB00543
Drug	AL-3138	TBXA2R PTGER2	8.80e-05	8	41	2	CID005311237
Drug	TEI-3356	TBXA2R PTGER2	8.80e-05	8	41	2	CID006439368
Drug	AC1L1JSB	CS CHIA	8.80e-05	8	41	2	CID000055790
Drug	AM 1241	CHRM1 CHRM4	8.80e-05	8	41	2	ctd:C439263
Drug	Cocaine	SLC6A4 CHRM1	8.80e-05	8	41	2	DB00907
Drug	Maprotiline	CHRM1 CHRM4	8.80e-05	8	41	2	DB00934
Drug	oxotremorine M	CHRM1 CHRM4	8.80e-05	8	41	2	ctd:C042743
Drug	ketanserin	TBXA2R SLC6A4 PLCD4 CHRM1	8.99e-05	131	41	4	CID000003822
Drug	hyaluronan	TBXA2R PRSS2 CHIA PTGER2 PGBD3	1.06e-04	263	41	5	CID000024759
Drug	Tei-9063	TBXA2R PTGER2	1.13e-04	9	41	2	CID005311245
Drug	DGM-2	TGM1 CHRM1	1.13e-04	9	41	2	CID000016891
Drug	benzo(F)quinoxaline	C2 CHRM1	1.13e-04	9	41	2	CID000098494
Drug	oxadiazoles	SLC6A4 CHRM1	1.13e-04	9	41	2	CID010523409
Drug	Pt-W	TGM1 C2	1.13e-04	9	41	2	CID000143061
Drug	AC1MJ5M1	PRSS2 MME	1.13e-04	9	41	2	CID003086119
Drug	Minaprine	SLC6A4 CHRM1	1.13e-04	9	41	2	DB00805
Drug	17-phenyl-trinor-prostaglandin E2	TBXA2R PTGER2	1.41e-04	10	41	2	CID000001450
Drug	Bethanechol	CHRM1 CHRM4	1.41e-04	10	41	2	ctd:D018723
Drug	1,2,4-thiadiazole	TGM1 CHRM1	1.41e-04	10	41	2	CID006451464
Drug	Promethazine	CHRM1 CHRM4	1.41e-04	10	41	2	DB01069
Drug	amphetamine	SLC6A4 C2 MME CS CHRM1	1.51e-04	284	41	5	CID000003007
Drug	U46619	TBXA2R C2 PLCD4 PTGER2 CHRM1	1.54e-04	285	41	5	CID000005618
Drug	DCCD	TBXA2R C2 PRSS2 PTGER2	1.56e-04	151	41	4	CID000010868
Drug	citramalate	C2 CS	1.72e-04	11	41	2	CID000001081
Drug	Pancuronium	CHRM1 CHRM4	1.72e-04	11	41	2	ctd:D010197
Drug	rocuronium	CHRM1 CHRM4	1.72e-04	11	41	2	ctd:C061870
Drug	Lys-Bradykinin	PRSS2 MME PTGER2	1.73e-04	60	41	3	CID000009569
Drug	isocitrate	C2 PRSS2 CS CHRM1	1.76e-04	156	41	4	CID000001198
Drug	CaCl2	SLC6A4 C2 PRSS2 CHIA	1.76e-04	156	41	4	CID000024854
Drug	(?-Fluprostenol	TBXA2R PLCD4 PTGER2	1.81e-04	61	41	3	CID000003391
Drug	arginine methyl ester	TBXA2R PRSS2 CHRM1	1.81e-04	61	41	3	CID000092932
Drug	AC1L1I1P	C2 CS HLA-DRB5	1.90e-04	62	41	3	CID000004385
Drug	TG-2	TGM1 TGM3 PRSS2	2.00e-04	63	41	3	CID000574319
Drug	GR63799	TBXA2R PTGER2	2.06e-04	12	41	2	CID005311224
Drug	AC1Q637U	PRSS2 CHIA	2.06e-04	12	41	2	CID000004869
Drug	Chlorprothixene	CHRM1 CHRM4	2.06e-04	12	41	2	DB01239
Drug	Vecuronium Bromide	CHRM1 CHRM4	2.06e-04	12	41	2	ctd:D014673
Drug	phenylphosphonic acid	C2 MME	2.06e-04	12	41	2	CID000015295
Drug	5'-sulfamoyladenosine	TGM1 MME CD22	2.09e-04	64	41	3	CID000097576
Drug	AC1L22WP	TGM1 TGM3 CHIA	2.29e-04	66	41	3	CID000065254
Drug	chlorzolamide	C2 TNFRSF25	2.44e-04	13	41	2	CID000165323
Drug	ZK118182	TBXA2R PTGER2	2.44e-04	13	41	2	CID005311208
Drug	MB28767	TBXA2R PTGER2	2.44e-04	13	41	2	CID005311223
Drug	N-0164	TBXA2R PTGER2	2.44e-04	13	41	2	CID000173763
Drug	alaproclate	SLC6A4 CHRM1	2.44e-04	13	41	2	CID000002081
Drug	NSC292567	TBXA2R C2 MCOLN1	2.50e-04	68	41	3	CID000004489
Drug	silver nanoparticles	TGM1 CHIA CD22 CNGA1	2.56e-04	172	41	4	CID000023954
Drug	Methyl Parathion	TGM1 CHRM1 CHRM4	2.61e-04	69	41	3	ctd:D008743
Disease	aspirin-induced respiratory disease (is_implicated_in)	TBXA2R CACNG6 HLA-DRB4	4.39e-07	11	42	3	DOID:0080822 (is_implicated_in)
Disease	asthma (is_implicated_in)	TBXA2R SLC6A4 CHIA CHRM1	7.38e-05	157	42	4	DOID:2841 (is_implicated_in)
Disease	Asthma, Aspirin-Induced	TBXA2R PTGER2	1.53e-04	13	42	2	C1319853
Disease	Amphetamine-Related Disorders	SLC6A4 DCSTAMP CSMD1	1.69e-04	75	42	3	C0236733
Disease	Amphetamine Abuse	SLC6A4 DCSTAMP CSMD1	1.69e-04	75	42	3	C0236807
Disease	Amphetamine Addiction	SLC6A4 DCSTAMP CSMD1	1.69e-04	75	42	3	C0236804
Disease	neutrophil collagenase measurement	C2 ABCA13	2.34e-04	16	42	2	EFO_0008248
Disease	ubiquitin carboxyl-terminal hydrolase 25 measurement	C2 HLA-DRB5	4.49e-04	22	42	2	EFO_0021881
Disease	congestive heart failure (biomarker_via_orthology)	MME CS CHRM4	4.80e-04	107	42	3	DOID:6000 (biomarker_via_orthology)
Disease	response to vaccine	C2 CSMD1 HLA-DRB5	7.04e-04	122	42	3	EFO_0004645
Disease	cerebrospinal fluid clusterin measurement	CSMD1 ABCA13	1.14e-03	35	42	2	EFO_0007657
Disease	response to radiation, prostate carcinoma, erectile dysfunction	CELA2B CELA2A	1.28e-03	37	42	2	EFO_0001663, EFO_0004234, GO_0009314

Protein segments in the cluster

Peptide	Gene	Start	Entry
SIGYWLCYVNSTINP	CHRM4	436	P08173
GYPNYANCTWIIITG	CSMD1	51	Q96PZ7
CYFTNWAQYRPGLGR	CHIA	26	Q9BZP6
YFLCGWYLSNLIPGT	ABCA13	3766	Q86UQ4
NNYPCYVTGWGRLQT	CELA2A	151	P08217
PRLTYEYSWSLGCGV	CACNG6	211	Q9BXT2
LATWYLEAVCPGQYG	ABCA7	746	Q8IZY2
PWTNGSGLALCQRYY	MCOLN1	156	Q9GZU1
CSVNGFYPGSIEVRW	HLA-DRB5	146	Q30154
VWSGTEPICRQPYSY	C2	196	P06681
PNSGQSWYFLGRCYS	KDM6A	281	O15550
GQYVQYCPGTWCFIR	PTGER2	176	P43116
GPCGWKYENIYITRQ	DCSTAMP	236	Q9H295
AQVWCGTYRPEYAVN	MME	691	P08473
GQYRCYGAHNLSPRW	LILRB5	291	O75023
NNYPCYVTGWGRLQT	CELA2B	151	P08218
YIWNTLNSGRVVPGY	CS	331	O75390
LPRLYGGYQTDWVCG	FAM120C	126	Q9NX05
ELGYWLCYVNSTINP	CHRM1	401	P11229
CSVNGFYPGSIEVRW	HLA-DRB4	146	P13762
TCLGWYRQCNIIPYS	FKTN	301	O75072
PNWYEFSGCRQIGSL	CRYBG1	1566	Q9Y4K1
WCGITPQGYYRRTAE	CERCAM	181	Q5T4B2
LVISTWNGYYECRPQ	DMBT1	2151	Q9UGM3
ICPNIWLEYGQYSVG	SART3	181	Q15020
SCYGYPIQLQWLLEG	CD22	166	P20273
ATCLGYICWFQPYQG	PGBD3	301	Q8N328
GQYTLPWTCMQQGYR	PLCD4	716	Q9BRC7
YYTGVLCGLGWNPAT	TDRD9	1246	Q8NDG6
LTQPWYSGNCDRYAV	SH2D6	61	Q7Z4S9
YCANWTPGAIGLYTL	MYCBP2	2411	O75592
IWRFPYLCQTYGGGA	SLC6A18	41	Q96N87
SPVRYGQCWVFAGTL	TGM3	266	Q08188
PSGNTYYNWLFCITL	CNGA1	156	P29973
THQGINPYRCSWYGK	ZNF75CP	341	Q92670
WGYGCAQKNRPGVYT	PRSS2	216	P07478
ICTVQLVGNSWTPGY	TNFRSF25	271	Q93038
LRTGYSVPYGQCWVF	TGM1	366	P22735
VGRYTVQYPGSWCFL	TBXA2R	171	P21731
PYWSIILGYCIGTSS	SLC6A4	571	P31645
LGNVWRFPYLTYSNG	SLC6A14	56	Q9UN76
LTWIYYTRCGGPQQS	SIGLEC14	376	Q08ET2